Page 503 - O_Desenvolvimento_do_Autismo
P. 503

FILIPEK, P.; ACCARDO, P. J.; BARANEK, G. T.; Cook, E. H.; DAWSON,
                G.; GORDON, B.; GRAVEL, J. S.; JOHNSON, C. P.; KALLEN, R. J.; LEVY,
                S. E.; MINSHEW, N. J.; PRIZANT, B. M.; RAPIN, I.; ROGERS, S. J.;

                STONE, W. L.; TEPLIN, S.; TUCHMAN, R. F. e VOLKMAR, F. “The
                screening and diagnosis of autistic spectrum disorders.” Journal of Autism
                and Developmental Disorders 29, (6), 1999, pp. 439-484.






                FINDLING, R. L.; MAXWELL, K.; SCOTESE-WOJTILA, L.; HUANG, J.;
                YAMASHITA, T. e WIZNITZER, M. “High-dose pyridoxine and magnesium
                administration in children with autistic disorder: an absence of salutary
                effects in a double-blind, placebo-controlled study”. Journal of Autism and
                Developmental Disorders 27(4), 1997, pp. 467-478.







                FLAVELL, J. H. “Metacognition and cognitive monitoring: a new era of
                cognitive-developmental inquiry”. American Psychologist 34, 906-911.






                _____. “Metacognitive development”. In: J. Scandura e C. Brainerd (eds.).
                Structural process theories of complex human behavior. Leyden: Sijthoff,
                1978.






                FOLSTEIN, S. e ROSEN-SHEIDLEY, B. “Genetics of autism: complex
                aetiology for a heterogeneous disorder”. Nature Reviews Genetics 2(12),

                2001, pp. 943-955.






                FOMBONNE, E. “Is the prevalence of autism increasing?” Journal of Autism
                and Developmental Disorders 26, 1996, pp. 673-676.
   498   499   500   501   502   503   504   505   506   507   508